Candidiasis after antibiotics: symptoms and treatment

Post-antibiotic candidiasis is an inflammation caused by yeast-like fungi of the genus Candida that develops when the normal microbiota is disrupted after antibiotic therapy. The vagina, vulva, and oral cavity are most commonly affected, while the skin of the folds and esophagus are less commonly affected. For most immunocompetent individuals, this is an unpleasant but manageable condition; however, with risk factors, the course can be protracted and recurring. The CDC emphasizes that treatment typically involves topical azoles or a single dose of fluconazole, but confirmation of the diagnosis is advisable before initiating therapy. [1]

Antibiotics suppress sensitive bacterial flora, including lactobacilli, which normally inhibit the growth of Candida. As a result, yeast fungi gain a competitive advantage and are able to more actively colonize mucous membranes. Observational and experimental studies confirm an increase in Candida carriage and a higher incidence of symptomatic vulvovaginal candidiasis after courses of antibiotics. [2]

The clinical presentation depends on the location: vulvovaginal candidiasis is characterized by itching, burning, a cheesy discharge, and pain, while oral candidiasis is characterized by painful white plaques, cracks at the corners of the mouth, and taste disturbances. Symptoms range from mild to severe, with swelling and fissures of the vulva. In case of relapse, it is important to distinguish reinfection from persistence and assess the underlying factors. [3]

The treatment approach is stepwise: first, confirming the clinical diagnosis, then selecting a proven therapy, and addressing relapse risk factors. Current guidelines from the CDC, NICE, and IDSA provide clear regimens for acute episodes, severe forms, and relapsing illnesses, including 6-month maintenance courses. [4]

Code according to ICD-10 and ICD-11

The International Classification of Diseases, Tenth Revision, classifies vulvovaginal candidiasis under section B37 "Candidiasis," with separate codes for this condition. This is important for statistics, insurance claims, and the proper prescription of therapy. In addition to the vulvovaginal form, this section describes oral candidiasis and other localizations. [5]

The International Classification of Diseases, Eleventh Revision, includes a section on "Candidiasis," where vulvovaginal candidiasis has its own code and description, focusing on clinical features and confirmation methods. ICD-11 supports post-coordination, allowing for clarification of severity, course, and associated factors, which is useful for complex cases and relapses. [6]

Table 1. Codes for candidiasis according to ICD-10 and ICD-11

Classification	Chapter	Code	Name
ICD-10	B37	B37.0	Oral candidiasis
ICD-10	B37	B37.3	Candidiasis of the vulva and vagina
ICD-10	B37	B37.31 B37.32	Acute and chronic candidiasis of the vulva and vagina
ICD-11	1F23	1F23.10	Vulvovaginal candidiasis
ICD-11	1F23	1F23.Z	Other specified candidiasis

Sources: official code resources. [7]

Epidemiology

Vulvovaginal candidiasis is one of the most common causes of vaginal itching and discharge in women of reproductive age. According to review articles and clinical guidelines, most women experience at least one episode during their lifetime, and a significant proportion experience recurrent episodes. The risk increases with broad-spectrum antibacterial therapy. [8]

Antibiotics increase the likelihood of a symptomatic episode in the short term. Observational studies show an increase in the frequency and colonization of Candida immediately after treatment and in the following weeks, with the risk correlating with the duration and spectrum of the medication. These findings have been confirmed in several primary care studies. [9]

A recurrent course is defined as 3-4 or more episodes within 12 months. For such cases, guidelines recommend 6-month maintenance regimens, as without prophylaxis, the risk of relapse remains high. Comorbid conditions, hormonal factors, and behavioral habits influence the likelihood of relapse. [10]

Oral candidiasis most often occurs in the elderly, smokers, those wearing dentures, and after antibiotics and inhaled glucocorticosteroids. In the absence of severe underlying diseases, the prognosis is favorable with appropriate local therapy. [11]

Table 2. Epidemiological and natural history facts

Indicator	Key information
Antibiotic Link	Increased Candida colonization and symptom frequency in the weeks following treatment
Relapsing course	At least 3-4 episodes in 12 months
High-risk groups	Women of reproductive age, patients after broad spectrum courses
Natural course	Most immunocompetent patients have a good quality process with a good response to therapy.

Sources: review studies and clinical guidelines. [12]

Reasons

The main cause is dysbiosis following antibacterial therapy: suppression of normal bacterial flora reduces competition for Candida and facilitates its growth. This is a biologically plausible mechanism, supported by colonization data and clinical observations. The broader the spectrum and the longer the course, the higher the risk. [13]

Candida albicans is the most common causative agent, but non-albicans species, such as Candida glabrata, which may be less sensitive to azoles, are increasingly being isolated. This is important to consider in cases of relapses and the ineffectiveness of standard regimens, when mycological confirmation with species identification is warranted. [14]

Additional causes include local factors: mucosal irritation, microtrauma, and the use of harsh detergents and spermicides. These factors disrupt the barrier and facilitate colonization. Eliminating these factors is part of treatment and prevention. [15]

In some patients, systemic influences predominate: hormonal fluctuations, diabetes, and immune disorders. These are not necessarily caused by antibiotics, but they worsen outcomes and increase the risk of recurrence after each provoking course. [16]

Risk factors

A course of broad-spectrum antibiotics, especially long-term ones, is the main modifiable risk factor associated with an episode of candidiasis shortly after treatment. When given a choice, a narrow spectrum and a minimally sufficient duration are preferable, which reduces the likelihood of dysbiosis. [17]

Other factors include the use of combined hormonal contraceptives, uncontrolled diabetes, tight synthetic underwear, high humidity, and exposure to irritants. These factors aggravate symptoms and increase the likelihood of relapse. Lifestyle modification counseling is part of the management. [18]

The risk of recurrence is increased in patients with previous episodes and in those who frequently receive antibiotics for sinusitis, bronchitis, and urinary tract infections. In such cases, it is reasonable to discuss maintenance regimens or early treatment at the first sign of recurrence. [19]

For oral candidiasis, risk factors include dentures, smoking, xerostomia, and inhaled glucocorticosteroids, especially after a recent course of antibiotics. Adjusting personal care habits improves treatment effectiveness. [20]

Table 3. Main risk factors after antibiotics

Group	Examples
Medicinal	Broad spectrum, long course, frequent repeat courses
Metabolic	Diabetes mellitus, hormonal influences
Behavioral	Synthetic tight underwear, humid environment, irritants
Dental	Dentures, xerostomia, inhaled glucocorticosteroids

Sources: clinical guidelines and reviews. [21]

Pathogenesis

Post-antibiotic dysbiosis leads to a decrease in the concentration of protective lactobacilli and an increase in vaginal pH, which removes restrictions on Candida growth. The fungi transition from a commensal state to active colonization and invasion of the surface epithelium, triggering an inflammatory response. This process is supported by Candida enzymes and adhesins. [22]

Candida albicans can form pseudomycelium and biofilms, which complicates elimination and contributes to relapse. Non-albicans species often exhibit reduced susceptibility to standard azoles, necessitating a change in strategy during relapses. Species identification is becoming clinically significant. [23]

In the oral cavity, antibiotics disrupt the balance of microbiota, reducing competition for Candida on the buccal mucosa, tongue, and soft palate. This easily leads to the development of characteristic white plaque and soreness. Topical therapy with nystatin or miconazole, when used correctly, quickly relieves symptoms. [24]

In susceptible individuals, a vicious cycle develops: dysbiosis, inflammation, discomfort, decreased quality of life, and the risk of repeated self-medication without confirmation of the diagnosis. Breaking this cycle is the goal of modern management with confirmation and clear guidelines. [25]

Symptoms

Vulvovaginal candidiasis is characterized by severe itching and burning, a cheesy white discharge without a strong odor, and pain during intercourse and urination. In severe cases, swelling, redness, cracking, and pain when walking are observed. Symptoms usually develop days or weeks after a course of antibiotics. [26]

Oral candidiasis is characterized by white or cream-colored plaque, soreness, a burning sensation on the tongue, cracks in the corners of the mouth, and a loss of taste. The plaque is easily removed with a spatula, leaving a hyperemic surface, which helps differentiate the condition from leukoplakia. The pain is aggravated by spicy foods and carbonated drinks. [27]

Systemic symptoms are usually absent in immunocompetent adults. The development of high fever, painful fissures, severe swelling, and intractable pain requires an in-person examination. In patients with diabetes, healing is slower and relapses are more common. [28]

In recurrent cases, symptoms recur 3-4 or more times per year, often after another antibiotic. It's important to identify triggers and discuss preventative and maintenance options with your doctor. [29]

Classification, forms and stages

Depending on the location, vulvovaginal candidiasis, oral candidiasis, and cutaneous candidiasis of the folds are distinguished. In the context of antibiotics, the vulvovaginal and oral forms are more common. Each has its own optimal first-line therapy and care requirements. [30]

Based on severity, episodes are classified as uncomplicated or complicated. Complicated episodes include severe forms with significant swelling and fissures, recurrent disease, pregnancy, diabetes, and suspected non-albicans species. For these cases, longer courses and maintenance regimens are recommended. [31]

Based on the course of the disease, acute single episodes, frequent episodes, and recurrent candidiasis are distinguished. For the latter, induction treatment is indicated, followed by 6-month maintenance therapy, with a review of the strategy after six months. This reduces the frequency of exacerbations and improves quality of life. [32]

Staging in the classical sense is not used, but in practice, symptom dynamics are assessed during therapy, which helps promptly change the approach if a response is not achieved within the expected timeframe. For the oral form, such monitoring is especially useful for dentures. [33]

Complications and consequences

Persistent itching, pain, and cracking can disrupt sleep, intimacy, and daily activities. Incorrect self-treatment without a confirmed diagnosis can mask other causes of discharge and itching, including bacterial vaginosis and trichomoniasis, prolonging the path to recovery. [34]

With severe inflammation, secondary bacterial infection and the formation of painful erosions are possible. Aggressive care methods and irritants increase barrier damage and contribute to chronicity. Therefore, gentle care and the correct choice of medications are important. [35]

In patients receiving frequent courses of antibiotics, recurrences of candidiasis may occur regularly, requiring a preventative strategy and dialogue with the treating physician about future approaches to antibacterial therapy. Selecting a narrower spectrum and a rational duration of treatment reduces the risk. [36]

Left untreated, oral candidiasis associated with dentures can cause chronic denture stomatitis, burning sensations, decreased taste, and a refusal to eat solid foods. Proper hygiene and topical therapy can prevent these problems. [37]

When to see a doctor

Consult a doctor immediately if severe pain, significant swelling, cracks, fever occur, or if symptoms do not subside within 3-5 days of starting treatment. Severe cases require longer courses and sometimes laboratory confirmation to identify the Candida species. [38]

Consultation is necessary if episodes recur 3-4 or more times within 12 months. In such cases, maintenance treatment for 6 months and an assessment of provoking factors, including the antibiotic regimen, glucose levels, and comorbidities, are discussed. [39]

Pregnant women with symptoms require an in-person consultation and the selection of topical azoles based on the duration and safety of treatment. Self-medication with systemic medications without a doctor's prescription is unacceptable. If a non-albicans species is suspected, the regimen must be adjusted. [40]

In the oral form, if plaque persists despite proper use of topical agents, an examination is required to assess denture care and eliminate risk factors. Sometimes, changing the denture base and drying the appliance overnight can be helpful. [41]

Diagnostics

The first step is a clinical assessment of symptoms and examination. For vulvovaginal candidiasis with a typical presentation and no complicating factors, empirical treatment is acceptable. However, in cases of relapse and treatment failure, smear microscopy and culture with species and susceptibility determination are recommended. This helps identify non-albicans strains. [42]

NICE recommends confirming the diagnosis in patients with recurrent episodes or an atypical course, and excluding other causes of discharge. If a severe form is suspected or during pregnancy, local regimens and investigations are preferred as indicated. [43]

For oral candidiasis, the diagnosis is often clinical. If the clinical picture is unclear or there is no response to therapy, cultures are performed and risk factors are considered, including dry mouth and monitoring of inhaled glucocorticosteroids. Denture care is a critical part of the plan. [44]

Blood laboratory tests are generally not necessary in immunocompetent adults with localized forms. The development of systemic symptoms or suspicion of an invasive process requires immediate referral and management according to IDSA guidelines, but this is a rare situation in uncomplicated post-antibiotic candidiasis. [45]

Table 4. Step-by-step diagnostic algorithm

Step	What are we doing?	For what
1	Clinical assessment of symptoms and examination	Determine the typical picture and severity
2	Microscopy and culture for relapse or failure	Identify non-albicans species and refine tactics
3	Exclusion of alternative causes of discharge	Reduce the risk of incorrect treatment
4	For the oral form - assessment of care and dentures	Eliminate triggers and improve therapy effectiveness

Sources: CDC, NICE. [46]

Table 5. Differential diagnosis

State	Distinguishing features	Tips for the doctor
Bacterial vaginosis	Gray discharge, strong odor, mild itching	Confirmation criteria, response to metronidazole
Trichomoniasis	Foamy discharge, severe irritation	PCR testing, treatment with antiprotozoal drugs
Dermatitis and contact reactions	Burning and itching without cheesy discharge	Search for irritants, skin tests as indicated
Leukoplakia of the oral cavity	Dense coating that cannot be removed with a spatula	Examination by a specialist, biopsy if in doubt

Sources: CDC, NICE, clinical reviews. [47]

Treatment

For uncomplicated vulvovaginal candidiasis, topical azoles for 7-14 days or fluconazole 150 mg orally as a single dose are recommended, with repeat administration after 72 hours in severe cases, as indicated. The choice depends on the severity of symptoms, preferences, and contraindications. If there are pronounced external symptoms, it is helpful to add imidazole cream to the vulvar skin. [48]

A severe episode with swelling and fissures requires extended therapy: topical azole for 7-14 days or fluconazole 150 mg twice at 72-hour intervals. This increases the clinical response rate and reduces the risk of early relapse. Monitoring is necessary after 7-14 days. [49]

Recurrent disease is managed in two stages. First, induction until clinical and mycological clearance is achieved, followed by maintenance: fluconazole 150-200 mg once weekly for 6 months. Alternatively, long-term courses of topical azoles are prescribed. After 6 months, the need for continuation is reassessed. [50]

If a non-albicans species, especially Candida glabrata, is suspected, standard azoles are less effective. In such situations, alternatives are used based on local protocols and culture results. The regimen is selected after confirming the species and assessing contraindications. [51]

For oral candidiasis, the first line is nystatin suspension or miconazole gel, using the correct technique: hold in the mouth for 2-3 minutes and then swallow. Improved denture hygiene, smoking cessation, and dryness management enhance the effect and reduce recurrence. [52]

The additional role of probiotics as adjuvants to antifungal therapy is being discussed. A Cochrane review and more recent studies suggest a possible improvement in short-term clinical and mycological response and a reduction in the rate of early relapses; however, the quality of evidence varies, and probiotics should be considered as an adjunct to, rather than a replacement for, conventional therapy. [53]

Rational antibiotic therapy in the future is an important part of preventing recurrences. When possible, a narrow spectrum of antibiotics is chosen, the shortest duration is sufficient, and preventive measures are discussed during the expected courses. This reduces the likelihood of subsequent episodes of candidiasis. [54]

Table 6. Treatment regimens for vulvovaginal candidiasis

Situation	First line	Alternative
Uncomplicated episode	Topical azole 7-14 days or fluconazole 150 mg once	Repeat fluconazole 150 mg after 72 hours for moderate cases
A difficult episode	Fluconazole 150 mg twice at 72-hour intervals or topical azole for 7-14 days	Individualization based on tolerance and risk factors
Recurrent variant	Induction, then fluconazole 150-200 mg weekly for 6 months	Long-term courses of topical azoles according to schedule
Suspected non-albicans species	Schemes based on sowing results	Individual selection

Sources: CDC, review publications. [55]

Table 7. Treatment of oral candidiasis

Preparation	How to apply	Important tips
Nystatin suspension	Hold in mouth for 2-3 minutes, then swallow, follow the instructions.	Take after meals, do not drink immediately
Miconazole gel	Apply to affected areas, hold and then swallow.	Use caution in interactions, monitor prostheses
Caring for dentures	Remove overnight, dry, and clean according to instructions.	Reduces relapses and inflammation

Source: Clinical practice guidelines for oral candidiasis. [56]

Table 8. Drug interactions and precautions

Situation	What to look out for
Fluconazole	Potential interactions with drugs metabolized through liver enzymes should be assessed according to the instructions.
Miconazole gel	Possible interactions if swallowed, consider concomitant therapy.
Pregnancy	Local azoles are preferred; systemic agents are prescribed by a doctor.
Associated diseases	In case of liver and kidney pathology - risk assessment and monitoring

Sources: CDC, NICE. [57]

Table 9. Five-step strategy for relapse

Step	Action
1	Confirm the diagnosis by microscopy and culture
2	Conduct induction until clinical and mycological clearance
3	Initiate 6-month maintenance regimen with fluconazole or topical azole
4	Exclude non-albicans species and modify plan as necessary
5	Revisit risk factors and approach to future antibiotics

Sources: CDC, review papers. [58]

Prevention

Discuss the need and duration of future courses of antibiotics with your doctor, choosing a narrow spectrum and the shortest possible duration. When considering a course of antibiotics, agree in advance on a plan of action at the first sign of candidiasis and on care measures. This reduces the likelihood of an episode. [59]

Maintain healthy habits: wear loose cotton underwear, avoid harsh detergents and spermicides, and practice gentle intimate hygiene without overdoing it. If you're prone to recurrence, it's helpful to discuss preventative treatments and adjuvant approaches. [60]

For your oral health, pay close attention to denture care, quit smoking, and manage dry mouth. Adherence to the correct technique for applying topical treatments increases effectiveness and reduces the duration of symptoms. [61]

The general rule is not to delay treatment if symptoms are severe and not to start repeat courses without confirming the diagnosis if relapses occur. This saves time and reduces the risk of complications. [62]

Forecast

In most immunocompetent patients, the acute episode is successfully managed with standard regimens within 3-14 days. Duration depends on the severity and adherence to recommendations, as well as the timeliness of therapy initiation. Recurrence of symptoms requires a reassessment of the treatment plan. [63]

Recurrent disease can be controlled with 6-month maintenance regimens, which significantly reduces the frequency of episodes and improves quality of life. After completion of maintenance, some patients remain in remission, but others require individualized prophylaxis for a longer period. [64]

The prognosis for the oral form is favorable with proper local therapy and denture care. If complaints persist, predisposing factors, including dryness and irritation, are identified and eliminated, which reduces the likelihood of relapse. [65]

Adverse outcomes are rare and are usually associated with severe underlying diseases. In such cases, management is carried out according to specialized protocols of infectious disease specialists and hematologists, which goes beyond uncomplicated post-antibiotic candidiasis. [66]

Answers to frequently asked questions

Why does candidiasis occur after antibiotics?
Because antibiotics disrupt the balance of normal flora, particularly lactobacilli, which normally inhibit the growth of Candida. Under dysbiosis, fungi gain an advantage and colonize mucous membranes more actively. The risk is higher with broad-spectrum and long-term treatments. [67]

What should you choose for an acute episode—a topical medication or fluconazole?
Both strategies are effective. For uncomplicated episodes, topical azoles for 7-14 days or a single dose of fluconazole 150 mg are appropriate. For severe symptoms, two doses of fluconazole 72 hours apart or a longer course of a topical azole are appropriate. The choice depends on preference and contraindications. [68]

How to treat relapses?
Initially, induction until complete clearance, followed by maintenance fluconazole once a week for 6 months or a long-term regimen of topical azole. After 6 months, the strategy is reevaluated. If a non-albicans species is suspected, the regimen is adjusted. [69]

Do probiotics help?
As an adjunct to standard therapy, probiotics may improve short-term cure rates and reduce the risk of early relapse, but they are not a substitute for antifungal medications. The evidence is mixed; consider them adjuvant. [70]

When are tests needed?
In cases of relapse, severe disease, pregnancy, failure of standard treatments, and suspected non-albicans infection. In other cases, in immunocompetent adults, the diagnosis is often made clinically and treatment is initiated without delay. [71]